(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ Composite: MACK) jumped 5.94% to $4.64 at 18:18 EST on Friday, after three consecutive sessions in a row of gains. NASDAQ Composite is rising 0.05% to $14,942.83, following the last session’s downward trend. This seems, as yet, a somewhat up trend exchanging session today.

Merrimack Pharmaceuticals’s last close was $4.38, 53.65% below its 52-week high of $9.45.


Today’s last reported volume for Merrimack Pharmaceuticals is 26430 which is 3.03% above its average volume of 25652.


Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 3.47%, 0.35%, and 2.43%, respectively.

Merrimack Pharmaceuticals’s highest amplitude of average volatility was 5.59% (last week), 2.38% (last month), and 2.43% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merrimack Pharmaceuticals’s stock is considered to be oversold (<=20).

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $4.64 at 18:18 EST, way under its 52-week high of $9.45 and way above its 52-week low of $3.83.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s value is higher than its 50-day moving average of $4.45 and way under its 200-day moving average of $5.62.

More news about Merrimack Pharmaceuticals (MACK).


Please enter your comment!
Please enter your name here